← Browse by Condition
Medical Condition
smoking
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for smoking sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — smoking Clinical Trials
How many clinical trials are currently recruiting for smoking?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for smoking, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for smoking?
smoking research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a smoking clinical trial?
Eligibility criteria for smoking trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07223840 Phase 2
Recruiting
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Enrollment
222 pts
Location
United States, China...
Sponsor
Eli Lilly and Company
NCT06331819
Recruiting
Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
Enrollment
200 pts
Location
Jordan
Sponsor
Jordan Collaborating Cardiolog...
NCT04281979
Recruiting
Effects of a Specific Substance in Smokers
Enrollment
60 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
NCT06470321
Recruiting
Biopsychosocial Predictors of Nicotine Relapse
Enrollment
200 pts
Location
Cyprus
Sponsor
University of Cyprus
NCT07166120
Recruiting
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
Enrollment
112 pts
Location
United States
Sponsor
Washington University School o...
NCT05790486
Recruiting
Take A Break - Rural
Enrollment
800 pts
Location
United States
Sponsor
Wake Forest University Health ...
NCT05490927
Recruiting
Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
Enrollment
90 pts
Location
United States
Sponsor
University of Houston
NCT05660525
Recruiting
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
Enrollment
768 pts
Location
United States
Sponsor
University of Virginia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology